Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Join | Sign in
Home>News

  News Archive

Results from the Sidney Kimmel Cancer Center at Thomas Jefferson University
Tuesday, April 21, 2015
The Sidney Kimmel Cancer Center has published results of its work evaluating the potential for ANGLE’s Parsortix system.

Aprea Presents Preliminary Clinical Phase Ib/II Results in Ovarian Cancer at AACR
Tuesday, April 21, 2015
Company presents results with APR-246 - a novel candidate drug that restores mutant p53 protein into its wild-type function.

Gene Variant Linked to Smoking Longer, Getting Lung Cancer Sooner
Saturday, April 18, 2015
Smokers with a particular variation in a nicotine receptor gene were more likely to continue smoking for four years.

Scientists Discover Protein That Boosts Immunity to Viruses and Cancer
Saturday, April 18, 2015
Researchers now developing a gene therapy designed to boost the infection-fighting cells.

NIH Study Finds Genetic Link for Rare Intestinal Cancer
Friday, April 17, 2015
Researchers recommend screening for people with family history.

Potential For Prediction Of Progression For Early Form Of Breast Cancer
Friday, April 17, 2015
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.

Agendia Announces Recommendation of MammaPrint in Germany’s AGO Guidelines
Thursday, April 16, 2015
Company also highlights FDA clearance of MammaPrint in FFPE.

4SC Signs Licensing and Development Agreement with Menarini
Thursday, April 16, 2015
Licensing partnership for 4SC's cancer compound resminostat for the Asia-Pacific region excluding Japan.

Mechanism of Action of ABIVAX’s First-in-class Anti-HIV Drug Published
Wednesday, April 15, 2015
Novel mechanism of action - prevention of viral RNA exit from nucleus of infected cells - associated to unique anti-viral properties.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 3352
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters